Sensona, Inc., a prominent manufacturer in the medical and biotechnology fields, is dedicated to improving rapid and precise diagnostic solutions. Our cutting-edge technology, NOBORDERS, offers a 90-second qPCR diagnostic assay for common viral, including Influenza A, Influenza B, COVID-19, and Norovirus.
At Sensona, we focus on simplifying the diagnosis of infectious diseases using rapid molecular analysis. Our goal is to improve access to public health services and aid in the effective management of diseases, both in local settings and during pandemics, through our innovative technology and solutions.
OUR INNOVATIVE PLATFORM
Sensona is powered by innovative, patented technology based on DNA Nanotechnology, Pathology, and Molecular Diagnostics. Developed by a team of scientists and clinicians with more than twenty years of experience, our platform establishes new benchmarks for rapid and accurate diagnostic solutions.
Sensona, Inc. proudly presents our 90-second qPCR kit, highlighting the fast and user-friendly of our diagnostic solutions, which offer the same simplicity as a pregnancy test.
MEET OUR EXPERT TEAM
Our experts combine a wealth of experience across various disciplines, such as science, industry, and marketing. With 20 years of collaborative success, our founders guide a dedicated team that is wholeheartedly focused on promoting advancements in medical and biotechnological innovations.